CINGW
Cingulate Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
−0.88%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-37.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 10, 2026 | Werth Peter J. · director | Purchase | 19,455 | $5.04 |
| Feb 10, 2026 | Werth Peter J. · director | Purchase | 15,564 | $5.04 |
| Feb 10, 2026 | Callahan Jennifer L. · officer: SVP and CFO | Purchase | 4,864 | $5.04 |
| Feb 10, 2026 | Callahan Jennifer L. · officer: SVP and CFO | Purchase | 3,891 | $5.04 |
| Feb 10, 2026 | Schaffer Shane J. · director, officer: Chief Executive Officer | Purchase | 6,809 | $5.04 |
| Feb 10, 2026 | Schaffer Shane J. · director, officer: Chief Executive Officer | Purchase | 5,447 | $5.04 |
| Feb 10, 2026 | Brams Matthew · officer: EVP and Chief Medical Officer | Purchase | 1,946 | $5.04 |
| Feb 10, 2026 | Brams Matthew · officer: EVP and Chief Medical Officer | Purchase | 1,556 | $5.04 |
| Jan 5, 2026 | Silva Raul R. · officer: EVP and CSO | A-Award | 6,625 | $4.34 |
| Nov 10, 2025 | Silva Raul R. · officer: EVP and CSO | A-Award | 7,334 | $3.92 |
| Nov 10, 2025 | Downey Bryan Wade · officer: Chief Commercial Officer | A-Award | 30,000 | $3.80 |
| Jul 10, 2025 | Patel Nilay Dahyabhai · officer: CLO and CCO | A-Award | 30,000 | $4.51 |
| Jul 9, 2025 | Silva Raul R. · officer: EVP and CSO | A-Award | 51,500 | $4.42 |
| Jul 9, 2025 | Myers Laurie · officer: EVP and COO | A-Award | 31,000 | $4.42 |
| Jul 9, 2025 | Schaffer Shane J. · director, officer: Chief Executive Officer | A-Award | 199,500 | $4.42 |
| Jul 9, 2025 | Callahan Jennifer L. · officer: SVP and CFO | A-Award | 64,500 | $4.42 |
| Jul 9, 2025 | Brams Matthew · officer: EVP and Chief Medical Officer | A-Award | 52,500 | $4.42 |
| Jul 1, 2025 | Silva Raul R. · officer: EVP and CSO | A-Award | 1,000 | $4.30 |
| Jun 23, 2025 | Ervin Jeffrey S · director | A-Award | 15,000 | $4.14 |
| Jun 23, 2025 | ROBERTS JOHN A · director | A-Award | 15,000 | $4.14 |
| Jun 23, 2025 | Lawrence Bryan Jay · director | A-Award | 15,000 | $4.14 |
| Jun 23, 2025 | Werth Peter J. · director | A-Award | 15,000 | $4.14 |
| Feb 20, 2025 | Callahan Jennifer L. · officer: SVP and CFO | A-Award | 21,140 | $4.32 |
| Feb 20, 2025 | Myers Laurie · officer: EVP and COO | A-Award | 17,630 | $4.32 |
| Feb 20, 2025 | Schaffer Shane J. · director, officer: Chief Executive Officer | A-Award | 70,489 | $4.32 |
| Feb 20, 2025 | Brams Matthew · officer: EVP and Chief Medical Officer | A-Award | 17,630 | $4.32 |
| Feb 20, 2025 | Silva Raul R. · officer: EVP and CSO | A-Award | 17,630 | $4.32 |
| Jan 22, 2025 | Callahan Jennifer L. · officer: SVP and CFO | A-Award | 11,539 | $4.76 |
| Jan 22, 2025 | Silva Raul R. · officer: EVP and CSO | A-Award | 2,748 | $4.76 |
| Jan 22, 2025 | Myers Laurie · officer: EVP and COO | A-Award | 9,319 | $4.76 |
Institutional positioning
13F filings over the trailing two quarters
New 2Increased 0Reduced 1Sold out 4
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CAPTRUST FINANCIAL ADVISORS | New Position | 15,200 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 11,486 | May 15, 2026 |
| GOALVEST ADVISORY LLC | Unchanged | 3,000 | Apr 13, 2026 |
| UBS GROUP AG | Reduced | 580 | May 5, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| GoalVest Advisory LLC | Sold Out | 0 | Apr 13, 2026 |
| CAPTRUST FINANCIAL ADVISORS | Sold Out | 0 | May 15, 2026 |
| CITADEL ADVISORS LLC | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 10, 2026